BNP Paribas Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-32,114
Closed -$2.33M – 960
2018
Q1
$2.33M Sell
32,114
-4,269
-12% -$325K 0.02% 611
2017
Q4
$2.74M Hold
36,383
– – 0.02% 596
2017
Q3
$2.8M Hold
36,383
– – 0.02% 599
2017
Q2
$2.72M Hold
36,383
– – 0.02% 604
2017
Q1
$2.42M Sell
36,383
-468
-1% -$31.2K 0.02% 619
2016
Q4
$2.4M Hold
36,851
– – 0.02% 614
2016
Q3
$2.61M Sell
36,851
-782
-2% -$57K 0.02% 651
2016
Q2
$2.78M Buy
+37,633
New +$2.6M 0.02% 625
2013
Q3
– Sell
-22,292
Closed -$1.41M – 831
2013
Q2
$1.41M Buy
+22,292
New +$1.45M 0.01% 628

Other funds holding NVS

BNP Paribas Asset Management's NVS Position: Q2 2018 in Review

BNP Paribas Asset Management sold out of Novartis (NVS) in Q2 2018, closing a stake of 32,114 shares — an estimated $2.33M sold.

BNP Paribas Asset Management first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $2.8M in Q3 2017. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

  • BNP Paribas Asset Management reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
  • BNP Paribas Asset Management sold 32,114 Novartis shares in Q2 2018, an estimated $2.33M.
  • BNP Paribas Asset Management first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
  • BNP Paribas Asset Management's Novartis position peaked at $2.8M in Q3 2017.
  • 987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on BNP Paribas Asset Management's 13F filing for Q2 2018, filed 1 Aug 2018.